Zhenji Capital
Overview
Zhenji Capital is a Chinese private equity firm specializing in late-stage investments in biotechnology and pharmaceutical sectors. The firm focuses on companies with disruptive potential in these industries, aiming to accelerate their growth and scalability. Zhenji Capital provides strategic capital and operational expertise to help portfolio companies achieve sustainable success. The firm's investment strategy emphasizes a hands-on approach, combining strategic capital with deep industry expertise to build resilient businesses that create long-term value and impact. Zhenji Capital partners with visionary entrepreneurs to build transformative companies across biotechnology, pharmaceuticals, and therapeutics sectors. Zhenji Capital's portfolio includes investments in companies such as IMPACT Therapeutics, a biotechnology firm specializing in cancer therapeutics. The firm is committed to fostering innovation and driving growth in the biotechnology and pharmaceutical industries, contributing to the advancement of healthcare solutions in China.
Investment Focus
- Companies in biotechnology, pharmaceuticals, and therapeutics sectors with disruptive potential
Portfolio Companies
Reach Zhenji Capital directly
Verified work email, phone and LinkedIn for the full team — one spreadsheet, one payment, yours to keep.
Unlock full contacts →Frequently asked questions about Zhenji Capital
What sectors does Zhenji Capital invest in?
Zhenji Capital invests in Pharmaceuticals, Biotechnology and Therapeutics, and is based in Guangdong, China. Zhenji Capital is listed as a private equity in the ConnectSafely investor database.
What stage does Zhenji Capital invest at?
Zhenji Capital backs companies at Growth, Late Stage and Pre-IPO, writing cheques of 50M - 50M.
Which regions does Zhenji Capital invest in?
Zhenji Capital invests across China.
What companies has Zhenji Capital invested in?
Zhenji Capital's portfolio includes IMPACT Therapeutics.
Last updated · Source: ConnectSafely investor database